Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Navigating the crypto market is easier with user-friendly investment approaches. This guide provides strategies designed for beginners.
21,210 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A hypothetical $10,000 investment in Lockheed Martin at the Iran conflict’s start would be down about 22% by late Apr...
MassMutual CEO Roger Crandall frames the mounting debt burden as a daily drag on households and long-term growth. The...
Investors are buzzing about SpaceX’s potential to reach a trillion-dollar value, a scenario sparked by Elon Musk’s co...
A Cytokinetics insider sale coincides with a stunning stock move. This article breaks down what the trade might signa...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
XYLD has delivered steady income, yet its upside is capped. This analysis details the hidden costs and current perfor...
Sam Altman raised questions about SpaceX's bold plan for AI data centers in space. This article breaks down the viabi...
I run my investments on my own, but I still reserve a passive sleeve to reduce risk and simplify life. This is how I ...
As pepsico (pep) 2026 earnings shape the near-term outlook, investors want clarity on growth drivers, costs, and capi...
A once-in-a-century pattern is popping up in 2026. The stock market doing something unusual has historical precedents...
Foreign R&D drives innovation across borders, but it carries subtle tax costs that can eat into profits. This guide e...